Our analysis, encompassing various cancer types sourced from the TCGA database, has unearthed a compelling relationship between CCL19 expression and cancer suppression, particularly evident in breast cancer (BRCA) and ovarian cancer (OV) cases (Figure 1A, 1B). The gene discussed is CCL19; the disease is invasive breast carcinoma.